Condition
Macular Edema clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Macular Edema clinical trials that are recruiting, at sites in 15 countries (most in United States (3), Australia (2), China (2)). By phase: Phase 2 (2), Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 15Countries
Newest Macular Edema clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MK-8748 vs. aflibercept for diabetic macular edema | Phase 3 | Long Beach, California and 19 other locations | Recruiting | Jul 15, 2026 |
| MK-8748 vs aflibercept for diabetic macular edema | Phase 3 | Gilbert, Arizona and 34 other locations | Recruiting | Jul 15, 2026 |
| BI 1815368 for centre-involved diabetic macular edema. | Phase 2 | Phoenix, Arizona and 96 other locations | Recruiting | May 8, 2025 |
| Evaluating KIO-104 for treating macular edema | Phase 2 | Sydney, New South Wales and 5 other locations | Recruiting | Feb 13, 2025 |
| Micropulsed laser treatment for macular edema in retinal dystrophies | — | Rome, RM | Recruiting | Aug 4, 2023 |
| Treatment for diabetic retinopathy with MS-553 | Phase 1 | Changsha, Hunan and 2 other locations | Recruiting | Dec 5, 2019 |
| Advanced imaging techniques for eye conditions | — | Paris | Recruiting | Oct 16, 2019 |
| Evaluating dyes for safer eye surgery | — | Linz and 2 other locations | Recruiting | Dec 5, 2011 |
All recruiting trials (8)
-
MK-8748 vs. aflibercept for diabetic macular edema
This trial tests whether the investigational medicine MK-8748 can treat diabetic macular edema as well as the standard treatment aflibercept in adults with diabetes.
-
MK-8748 vs aflibercept for diabetic macular edema
This trial tests whether MK-8748 can treat diabetic macular edema as well as the standard treatment aflibercept in people with diabetes.
-
BI 1815368 for centre-involved diabetic macular edema.
This study will test whether the oral medicine BI 1815368 can improve vision in adults with centre-involved diabetic macular edema and determine the best dose.
-
Evaluating KIO-104 for treating macular edema
This study is testing a new treatment called KIO-104 to see if it can safely help people with macular edema improve their vision.
-
Micropulsed laser treatment for macular edema in retinal dystrophies
This study is testing a new type of laser treatment to see if it can help reduce swelling in the eyes of people with inherited retinal diseases.
-
Treatment for diabetic retinopathy with MS-553
This study is testing a new oral medication called MS-553 to see if it can improve vision and reduce swelling in the eyes of people with diabetic retinopathy.
-
Advanced imaging techniques for eye conditions
This study is testing new advanced imaging techniques to see if they can help doctors better understand and diagnose eye diseases like retinitis pigmentosa and maculopathy.
-
Evaluating dyes for safer eye surgery
This study is testing two dyes used during eye surgery to see if they can make the procedure safer and more effective for patients with conditions like macular edema.
Related topics
Quick answers
How many Macular Edema clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (3 trials), Australia (2 trials), China (2 trials), United Kingdom (2 trials), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.